Stablecoin issuer Tether is reportedly working with United States representatives on stablecoin regulatory policy in the US.

Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations ...

BASED on New York Times journalist Diane Henriques’s account of the Madoff affair, The Wizard of Lies is a psychologically ...

A federal judge in Washington, D.C., on Thursday put the U.S. Securities and Exchange Commission's civil lawsuit against ...

The Texas Stock Exchange, a new venture backed by financial giants including BlackRock, Citadel Securities and Charles Schwab is targeting a 2026 launch after submitting paperwork late last month to ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces presentations featuring the Company ...

The furious pace of deregulation is gutting agencies intended to protect ordinary Americans, consumer advocates say. But ...

The CFTC and the U.S. SEC are planning to reopen discussions on how to effectively impose crypto regulation. One of the key ...

Data show Anaphylm maintains consistent stability and potency under extreme temperature and real-world conditions, including heat, freezing, and ...

Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

(AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 months AML patients treated demonstrated one-year ...